Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

May 2026; Volume 46,Issue 5

Review

  • Open Access
    Cytometry by Time-of-Flight for Profiling Therapeutic Response in Colorectal Cancer: Strengths, Limitations, and Translational Challenges
    ELEANDROS KYROS, ADAM MYLONAKIS, PAGONA KASTANAKI, RALLIA-ILIANA VELLIOU, ANDREAS PANAGAKIS, SPYRIDON DAVAKIS, NIKOLETTA DIMITRIOU, EVANGELOS FELEKOURAS and ALEXANDROS PAPALAMPROS
    Anticancer Research May 2026, 46 (5) 2297-2316; DOI: https://doi.org/10.21873/anticanres.18118

Experimental Studies

  • Open Access
    Gossypol Inhibits GLI3-dependent SHH Signaling to Selectively Target SPOP-deficient Breast Cancer Cells
    PATRICIA AUGUSTINE, JAZMIN CHAVARRIA and MARIEKE BURLESON
    Anticancer Research May 2026, 46 (5) 2317-2327; DOI: https://doi.org/10.21873/anticanres.18119
  • Open Access
    Musashi1 Enhances Cell Growth and Increases Chemoresistance in Neuroblastoma
    ELIZABETH D. COCHRAN, JINGBO QIAO, ARTI MACHCHHAR, JILLIAN C. JACOBSON, SULLIVAN MCCREERY and DAI H. CHUNG
    Anticancer Research May 2026, 46 (5) 2329-2344; DOI: https://doi.org/10.21873/anticanres.18120
  • Open Access
    Serum Extracellular Vesicles Double-positive for CD9 and CD147 or for CD9 and CD63 Decrease After Surgical Resection in Patients With Colorectal Cancer: Potential Biomarkers of Residual Tumor
    YUKARI ADACHI, TAKERU MATSUDA, SACHIKO INUBUSHI, KEISUKE YASUDA, RYOTA ITO, NAOTO SHIRAKAMI, TAKAAKI TACHIBANA, MASAKI IMAI, HIROKI KAGIYAMA, TAKAO TSUNEKI, MASAYUKI ANDO, MASAFUMI SAITO, YUTAKA SUGITA, TARO IKEDA, YASUFUMI KOTERAZAWA, TOMOAKI AOKI, HITOSHI HARADA, YASUNORI OTOWA, NAOKI URAKAWA, HIRONOBU GOTO, HIROSHI HASEGAWA, SHINGO KANAJI, KIMIHIRO YAMASHITA, ROBERT M. HOFFMAN and YOSHIHIRO KAKEJI
    Anticancer Research May 2026, 46 (5) 2345-2352; DOI: https://doi.org/10.21873/anticanres.18121
  • Open Access
    Sulfasalazine an Inhibitor of System xC− (Cystine/glutamate Antiporter), Combined With Recombinant Methioninase, Inhibits Both Cancer and Normal Cells, Suggesting Lack of Cancer Selectivity of Cysteine Restriction
    JINSOO KIM, QINGHONG HAN, SHUKUAN LI, BYUNG MO KANG, YUTA MIYASHI, TOMOYUKI ISHIGURO, MICHAEL BOUVET and ROBERT M. HOFFMAN
    Anticancer Research May 2026, 46 (5) 2353-2359; DOI: https://doi.org/10.21873/anticanres.18122
  • You have access
    Apoptotic Induction by 1,5-Diaryl-1,4-pentadien-3-one Derivatives in the HL60 Cell Line: In Vitro and In Silico Expression
    ARSHEE REHMAN, ZIA UDIN, YASAR SHAH, ABDUR RAUF, KHALAF F ALSHARIF, KHALID J. ALZAHRANI, ABDUL SABOOR PIRZADA, MARIA DAGLIA, MICHAEL ASCHNER and HAROON KHAN
    Anticancer Research May 2026, 46 (5) 2361-2373; DOI: https://doi.org/10.21873/anticanres.18123
  • You have access
    6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
    KYOTA ISHII and TOMOHIRO YANO
    Anticancer Research May 2026, 46 (5) 2375-2386; DOI: https://doi.org/10.21873/anticanres.18124
  • Open Access
    PD-1+Tim-3+CD103+ CD8+ Tumor-infiltrating Lymphocytes Are Associated With Favorable Outcomes in Colorectal Cancer
    DAIJIRO MATOBA, TAKURO SAITO, TAKEHIRO NODA, MAMORU UEMURA, AZUMI UEYAMA, HISASHI WADA, YUICHIRO DOKI and HIDETOSHI EGUCHI
    Anticancer Research May 2026, 46 (5) 2387-2401; DOI: https://doi.org/10.21873/anticanres.18125
  • You have access
    Evaluation of Combined Treatment With Atorvastatin and SREBP2 Inhibitors Against Colorectal Cancer Cells Under Two-dimensional and Three-dimensional Culture Models
    KYOTA ISHII, YUNO TAUCHI and TOMOHIRO YANO
    Anticancer Research May 2026, 46 (5) 2403-2415; DOI: https://doi.org/10.21873/anticanres.18126
  • You have access
    Isolation and Biological Evaluation of Breast Cancer Side Population Cells Using DyeCycle Violet
    AYA KUMAZAKI, YUKIHIKO OSAWA, KONATSU IMANAKA, YUKI OHMOTO, MAIKA YOKOE, YUTO MASAKI, HIROKAZU ODASHIMA, TAKAFUMI ONISHI and MANABU HATTORI
    Anticancer Research May 2026, 46 (5) 2417-2427; DOI: https://doi.org/10.21873/anticanres.18127
  • You have access
    Therapeutic Efficacy of PB101 and Chemotherapy Combination in Preclinical Gastric Cancer Models
    MINSUNG PARK, CHENG HYUN LEE, KUI-JIN KIM, SUNG-HYUN HWANG, JI HEA SUNG, MILANG NAM, MINSU KANG, WOOCHAN PARK, JI-WON KIM, JIN WON KIM, SE HYUN KIM, JEONGMIN SEO, EUN HEE JUNG, KOUNG JIN SUH, YU JUNG KIM, JEE HYUN KIM, HYE SEONG LIM, HYUN GUL YANG, EUN BYUL CHO and KEUN-WOOK LEE
    Anticancer Research May 2026, 46 (5) 2429-2443; DOI: https://doi.org/10.21873/anticanres.18128
  • You have access
    Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
    KEITA GOTO, KIYOHIRO ANDO, NORIKO MOTOI, TOSHIHIKO IIZUKA, HIROTAKA FUCHIZAWA, YUKI NAKAMURA, YUTA SANO, SHOTARO MATSUOKA, HISANORI TAKENOBU, MASAYUKI HARUTA, RITSUKO ONUKI, YOH MATSUOKA, TAKEHIKO KAMIJO and YUKIO KAGEYAMA
    Anticancer Research May 2026, 46 (5) 2445-2453; DOI: https://doi.org/10.21873/anticanres.18129
  • You have access
    Proinsulin Promotes Tumor Development in the PANC-1 Pancreatic Adenocarcinoma Cell Line
    TOMONORI TSUYAMA, HANCHEN DONG, TAKENARI SATO, HIROHISA OKABE, HIROMITSU HAYASHI, MASAAKI IWATSUKI and KAZUYA YAMAGATA
    Anticancer Research May 2026, 46 (5) 2455-2465; DOI: https://doi.org/10.21873/anticanres.18130
  • You have access
    NK92-exo Induces Ferroptosis in A549 Cells by Targeting a miR-663a-SLC11A2 Axis
    DONG LAN, LIQIANG WEI, DENGHE LIU, YU-ANG MAO and JIANQUAN ZHANG
    Anticancer Research May 2026, 46 (5) 2467-2485; DOI: https://doi.org/10.21873/anticanres.18131
  • You have access
    Invasive-Front P21 Expression Is Associated With Tumor Aggressiveness in Head and Neck Squamous Cell Carcinoma
    SU IL KIM, MINJEONG KIM, JUNG WOO LEE, SUN LEE, HYUN JEE LEE, YOUNG-GYU EUN and YOUNG CHAN LEE
    Anticancer Research May 2026, 46 (5) 2487-2493; DOI: https://doi.org/10.21873/anticanres.18132
  • You have access
    Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells
    WEI-CHUN WANG, YING-TZU CHEN, FEI-TING HSU, BING-RU PENG and HSI-FENG TU
    Anticancer Research May 2026, 46 (5) 2495-2508; DOI: https://doi.org/10.21873/anticanres.18133
  • You have access
    IBP1 Represses the Migration and Invasion of Hepatocellular Carcinoma Cells by Inhibiting SOCE-dependent Formation of Neutrophil Extracellular Traps by Targeting the Akt Pathway
    YIFENG LOU, NI CHEN, JIONG ZHENG, XIANG JIANG, JINGDAN CHEN, QITAI WANG and QIANG CHEN
    Anticancer Research May 2026, 46 (5) 2509-2523; DOI: https://doi.org/10.21873/anticanres.18134
  • You have access
    Inhibition of AP-1 Reduces CD46-mediated Invasion of Bladder and Colon Cancer Cells
    THUY NGUYEN THI, VAN-TAN NGUYEN, HIEN DUONG THANH, SE-YOUNG KWON, JIN-HYUNG CHO, CHANGJONG MOON and CHAEYONG JUNG
    Anticancer Research May 2026, 46 (5) 2525-2539; DOI: https://doi.org/10.21873/anticanres.18135
  • You have access
    Metformin Induces PARP1-mediated Cell Death in NPC/HK1 Human Nasopharyngeal Carcinoma Cells
    CHIH-CHUN WANG, YAW-CHANG HUANG, CHIEF-CHUNG WANG, YINGXIAO LI and YU-YAN LAN
    Anticancer Research May 2026, 46 (5) 2541-2550; DOI: https://doi.org/10.21873/anticanres.18136
  • You have access
    Ubiquitin Ligase RNF149 Promotes Head and Neck Cancer Growth via Downregulation of CDKN2C
    YU-HSUAN HUNG, MIN-HONG WANG, LI-TZONG CHEN, MEI-REN PAN, HUI-CHING WANG, SIN-HUA MOI and CHI-WEN LUO
    Anticancer Research May 2026, 46 (5) 2551-2564; DOI: https://doi.org/10.21873/anticanres.18137
  • You have access
    Profiling of Lysine Lactylation Reveals Its Proliferation-promoting Functions in Colorectal Cancer Cells
    ZAIKUI ZHANG, HAIXIA TU, ZHONGYAN HAN, SHOUXING WANG, XIAOHUA WANG, YUXIAO ZHU, YUESHUAI GUO, CHENG CHEN and YAN LI
    Anticancer Research May 2026, 46 (5) 2565-2581; DOI: https://doi.org/10.21873/anticanres.18138

Clinical Studies

  • Open Access
    PRDX4 Potentially Serves as an Independent Marker for Early Recurrence of Oral Squamous Cell Carcinoma
    TAIJIRO HASHIMOTO, TAKERU OYAMA, YANGXIAN ZHANG, YUKINOBU ITO, JIA HAN, YAO LIU, MITSUAKI YOSHIDA, AKIHIRO SHIOYA, MASASHI OKURO, MORIMASA KITAMURA and SOHSUKE YAMADA
    Anticancer Research May 2026, 46 (5) 2583-2597; DOI: https://doi.org/10.21873/anticanres.18139
  • Open Access
    Real-world Delivery and Outcomes of Intravesical BCG for Non–muscle-invasive Bladder Cancer
    NOBUKI FURUBAYASHI, JIRO TSUJITA, AZUSA TAKAYAMA, YUTA SHIRAISHI, MOTONOBU NAKAMURA and TAKAHITO NEGISHI
    Anticancer Research May 2026, 46 (5) 2599-2608; DOI: https://doi.org/10.21873/anticanres.18140
  • You have access
    Identification of Risk Factors for the Local Recurrence of Hepatocellular Carcinoma Post-radiofrequency Ablation
    KOSUKE TANAKA, AKIFUMI KUWANO, MASAYOSHI YADA, HIDEO SUZUKI and KENTA MOTOMURA
    Anticancer Research May 2026, 46 (5) 2609-2618; DOI: https://doi.org/10.21873/anticanres.18141
  • You have access
    Robotic-assisted Distal Pancreatectomy Is Associated With Significant Reduction of Morphine Consumption for the Treatment of Acute Postoperative Pain
    AMELIE F. KRUSE, ANDREAS ANDREOU, HALUK MORGUL, MIRA KUELLMAR, SHADI KATOU, MAZEN A. JURATLI, CARSTEN SZARDENINGS, ANDREAS PASCHER, BENJAMIN STRUECKER and JENS P. HOELZEN
    Anticancer Research May 2026, 46 (5) 2619-2630; DOI: https://doi.org/10.21873/anticanres.18142
  • Open Access
    Evaluation of Quality Metrics for Dose Assessment in Field Overlap Regions of VMAT-Based Craniospinal Axis Irradiation
    CHRISTIAN ZIEMANN, FLORIAN CREMERS, LISA MUENDLEIN, CLAUDIA HOFFMANN, DIRK RADES and ANASTASSIA LÖSER
    Anticancer Research May 2026, 46 (5) 2631-2642; DOI: https://doi.org/10.21873/anticanres.18143
  • Open Access
    Early Progressive Disease Predicts Poor Outcomes of Second-line VEGFR Tyrosine Kinase Inhibitor Therapy After First-line Nivolumab Plus Ipilimumab in Advanced Renal Cell Carcinoma
    NOBUKI FURUBAYASHI, JIRO TSUJITA, AZUSA TAKAYAMA, YUTA SHIRAISHI, MOTONOBU NAKAMURA and TAKAHITO NEGISHI
    Anticancer Research May 2026, 46 (5) 2643-2651; DOI: https://doi.org/10.21873/anticanres.18144
  • You have access
    Prognostic Difference According to the Site of Origin (Major vs. Minor) of Salivary Gland Carcinoma
    MIOKO MATSUO, YUTARO KIDA, KAZUKI HASHIMOTO, RYUNOSUKE KOGO, NORITAKA KOMUNE, MASANOBU SATO, YUSUKE MIYAMOTO, TOMOMI MANAKO, SHOGO MASUDA and TAKASHI NAKAGAWA
    Anticancer Research May 2026, 46 (5) 2653-2661; DOI: https://doi.org/10.21873/anticanres.18145
  • You have access
    Pregabalin for Opioid-resistant Neuropathic Pain in Bone Metastases
    KIYOHIRO SAKAI, YASUKO IKEDA-SAKAI and HIROMICHI MATSUOKA
    Anticancer Research May 2026, 46 (5) 2663-2670; DOI: https://doi.org/10.21873/anticanres.18146
  • You have access
    Diameter of IPDA Is Associated With Maintenance of Hepatic Arterial Blood Flow in DP-CAR
    RYO MURANUSHI, ISAKU YOSHIOKA, NANA KIMURA, MINA FUKASAWA, AYANO SAKAI, YOSHIHIRO SHIRAI, TORU WATANABE, KATSUHISA HIRANO, KAZUTO SHIBUYA and TSUTOMU FUJII
    Anticancer Research May 2026, 46 (5) 2671-2681; DOI: https://doi.org/10.21873/anticanres.18147
  • You have access
    Macroscopic Tumor Color as a Surrogate for Biological Diversity in Clear Cell Renal Cell Carcinoma
    NOZOMI TSUJIO, CHISATO OHE, MASANORI SHIOHARA, NAO YUKIMATSU, TAKESHI YAMASAKI, MASAHIRO KATO, RENA UNO, JUNJI UCHIDA and KENICHI KOHASHI
    Anticancer Research May 2026, 46 (5) 2683-2692; DOI: https://doi.org/10.21873/anticanres.18148
  • You have access
    Effect of Increased Image Matrix on Lung Nodule Volumetry in Chest CT: A Phantom Study
    MIKE GULDIMANN, MONA EL-GEDAILY, BASTIAN CIMANDER, DANA BELDE, ANDRÉ EULER, JAKOB HEIMER, RAHEL A. KUBIK-HUCH and TILO NIEMANN
    Anticancer Research May 2026, 46 (5) 2693-2702; DOI: https://doi.org/10.21873/anticanres.18149
  • You have access
    Prognostic Significance of the Lymph Node Ratio in Obstructive Colorectal Cancer: A Retrospective Multicenter Study
    TOSHIO SHIRAISHI, TETSURO TOMINAGA, TAKASHI NONAKA, YUMA TAKAMURA, HIROKI KATAYAMA, SHINTARO HASHIMOTO, MARIKO YAMASHITA, KEISUKE NODA, KAZUKI MOTOYAMA, RIKA ONO, MAKOTO HISANAGA, AKIKO FUKUDA, MASAAKI MORIYAMA, FUMITAKE UCHIDA, MASAKI KUNIZAKI and KEITARO MATSUMOTO
    Anticancer Research May 2026, 46 (5) 2703-2711; DOI: https://doi.org/10.21873/anticanres.18150
  • You have access
    Potential of Inflammatory and Nutritional Markers and Clinicopathological Factors for Prognostic Prediction in Osteosarcoma
    KAZUHIKO HASHIMOTO, SHUNIJI NISHIMURA and KOJI GOTO
    Anticancer Research May 2026, 46 (5) 2713-2723; DOI: https://doi.org/10.21873/anticanres.18151
  • You have access
    Timing and Risk Factors for Hyperglycemia Associated With Anamorelin Administration
    YOSHIHIRO AMAKAWA, KAZUO KOBAYASHI, YUMA NONOMIYA, HISANORI SHIMIZU, KAZUYOSHI KAWAKAMI, TAKASHI YOKOKAWA, NAOKI SASAHIRA, MASATO OZAKA, TSUYOSHI TAKEDA, KENSEI YAMAGUCHI, DAISUKE TAKAHARI, MAKOTO NISHIO, RYO ARIYASU, TORU KITAZAWA and MASAKAZU YAMAGUCHI
    Anticancer Research May 2026, 46 (5) 2725-2733; DOI: https://doi.org/10.21873/anticanres.18152
  • You have access
    Laparotomy After Total Pelvic Exenteration: Current Status and Techniques for Ileal Conduit Preservation
    KOJI KOMORI, TAKASHI KINOSHITA, AKIRA OUCHI, TAKAYOSHI KISHIDA, TAKUYA KITAHARA, HIRONOBU YASUOKA, SHUICHIRO ANDO, SEIJI ITO, KAZUNARI MISAWA, YUICHI ITO, JUNPEI YAMAGUCHI, EIJI HIGAKI, TOMONARI ASANO, MASATAKA OKUNO, TAKAHIRO HOSOI, KOSUKE INADA, KIYOSHI NARITA, HIDENORI OJIO, MASASHI NEGITA, KOTARO OZAKI and TETSUYA ABE
    Anticancer Research May 2026, 46 (5) 2735-2741; DOI: https://doi.org/10.21873/anticanres.18153
  • You have access
    Recurrence Risk Stratification in Clear Cell Renal Cell Carcinoma Using TNM 2017 and WHO/ISUP Grade
    KOSUKE HAMADA, TAKESHI YAMASAKI, CHISATO OHE, NOZOMI TSUJIO, SHOMA YAMAMOTO, TAISUKE MATSUE, NAO YUKIMATSU, TAIYO OTOSHI, MINORU KATO, KATSUYUKI KURATSUKURI, MASANORI SHIOHARA, KENICHI KOHASHI and JUNJI UCHIDA
    Anticancer Research May 2026, 46 (5) 2743-2751; DOI: https://doi.org/10.21873/anticanres.18154
  • You have access
    Prognostic Impact of the Geriatric Nutritional Risk Index in Elderly Patients With Colorectal Cancer
    YASUNOBU KOBAYASHI, YASUHIRO TAKANO, ANNA FUKUSHIMA, TERUYUKI TAKISHIMA, TEPPEI KAMADA, YUTA IMAIZUMI, SHUNJIN RYU, YASUHIRO TAKEDA, HIRONORI KANNO, NOBUYOSHI HANYU and KEN ETO
    Anticancer Research May 2026, 46 (5) 2753-2762; DOI: https://doi.org/10.21873/anticanres.18155
  • Open Access
    A Reminder App for Optimizing Bladder Filling During Radiotherapy for Prostate Cancer: A Pre-study in Healthy Volunteers
    DIRK RADES, CARLOS A. NARVAEZ-WOLF, INGA C. ZWAAN, CHRISTINE VESTERGÅRD-MADSEN, CHARLOTTE KRISTIANSEN and JAN-DIRK KÜTER
    Anticancer Research May 2026, 46 (5) 2763-2770; DOI: https://doi.org/10.21873/anticanres.18156
  • You have access
    Practical Implementation and Validation of Geriatric Assessment in Older Adults With Esophageal Cancer
    TETSURO KAWAZOE, TOMONORI NAKANOKO, TOMOYA HARIMA, KEITA NATSUGOE, YUKI SHIN, SHO NAMBARA, YASUO TSUDA, KOJI ANDO, EIJI OKI and TOMOHARU YOSHIZUMI
    Anticancer Research May 2026, 46 (5) 2771-2779; DOI: https://doi.org/10.21873/anticanres.18157
  • You have access
    Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study
    TAKASHI NOJIRI, AKIISA OMURA, HIROSHI NISHIMURA, HIROSHI UDA, MICHIHITO KATAYAMA, KIYOTSUGU IEDE, YUKI TAKEYASU, UTAE KATSUSHIMA, HIROSHI OKADA and MASAHIKO HIGASHIYAMA
    Anticancer Research May 2026, 46 (5) 2781-2788; DOI: https://doi.org/10.21873/anticanres.18158
  • You have access
    Cancer Cachexia Predicts Benefit of Immunotherapy Plus Chemotherapy in EGFR-mutant NSCLC After TKI Resistance
    HARUKA NAKATANI, HAYATO KAWACHI, TADAAKI YAMADA, NAOKI FURUYA, HISASHI TANAKA, AKIHIRO YOSHIMURA, TOMOHIRO OBA, MAKOTO HIBINO, TAKAHITO FUKUDA, YASUHIRO GOTO, AKIRA NAKAO, SHINSUKE OGUSU, YUTA OKAZAKI, TAISHI HARADA, TAKAYO OTA, KEN MASUBUCHI, KOJI MIKAMI, TAE HATA, KENJI MORIMOTO and KOICHI TAKAYAMA
    Anticancer Research May 2026, 46 (5) 2789-2806; DOI: https://doi.org/10.21873/anticanres.18159
  • You have access
    Preoperative Cachexia Index Predicts Overall Survival Following Curative Resection for Remnant Gastric Cancer
    TOMOYUKI MATSUNAGA, JUNPEI ORIHARA, TOMOHIRO TAKAHASHI, SHOTA SHIMIZU, YUJI SHISHIDO, KOZO MIYATANI, MANABU YAMAMOTO, SYUICHI TAKANO, NARUO TOKUYASU, TERUHISA SAKAMOTO, HIROOMI OKUYAMA and YOSHIYUKI FUJIWARA
    Anticancer Research May 2026, 46 (5) 2807-2815; DOI: https://doi.org/10.21873/anticanres.18160
  • You have access
    Postoperative Changes in Nutritional Status and their Impact on Post-recurrence Prognosis After Pancreatoduodenectomy in Patients With Biliary Tract Carcinoma: An Age-stratified Analysis
    WATARU IZUMO, RYO SAITO, HIDETAKE AMEMIYA, SUGURU MARUYAMA, KOICHI TAKIGUCHI, KATSUTOSHI SHODA, KENSUKE SHIRAISHI, SHINJI FURUYA, YOSHIHIKO KAWAGUCHI, HIROMICHI KAWAIDA and DAISUKE ICHIKAWA
    Anticancer Research May 2026, 46 (5) 2817-2828; DOI: https://doi.org/10.21873/anticanres.18161

Special Issue on “Ovarian Cancer Immunology and Immunotherapy – 2026”

  • Editorial Note

    • Open Access
      Ovarian Carcer Immunology and Immunotherapy: Editorial Note
      CHRIS D. PLATSOUCAS
      Anticancer Research May 2026, 46 (5) 2829; DOI: https://doi.org/10.21873/anticanres.18162
  • Reviews

    • Open Access
      Recurrence and Malignant Transformation After Borderline Ovarian Tumors: A Systematic Review and Meta-analysis
      ANGELIKI TANISKIDI, EVANGELIA GIANNAS, SOFIA LEKKA, AIKATERINI TANISKIDI, ARABELLA LECOYTE, MARK BRINCAT, JAMES DILLEY, ARJUN JEYARAJAH, ALEXANDRA LAWRENCE, ELLY BROCKBANK, SAURABH PHADNIS, RANJIT MANCHANDA and MICHAIL SIDERIS
      Anticancer Research May 2026, 46 (5) 2831-2849; DOI: https://doi.org/10.21873/anticanres.18163
    • Open Access
      Metabolism-driven Immune Escape Defines Therapeutic Vulnerability in Type I and Type II Ovarian Cancer
      KOHEI MIYATA and FUSANORI YOTSUMOTO
      Anticancer Research May 2026, 46 (5) 2851-2861; DOI: https://doi.org/10.21873/anticanres.18164
    • Open Access
      Inflammatory Cytokine Genotypic Markers and Ovarian Cancer Risk
      WEN-SHIN CHANG, CHIA-WEN TSAI, JAW-CHYUN CHEN, YUN-CHI WANG and DA-TIAN BAU
      Anticancer Research May 2026, 46 (5) 2863-2876; DOI: https://doi.org/10.21873/anticanres.18165
  • Articles

    • Open Access
      Prognostic Relevance of FOS and JUN Family Members and Immune Cell Infiltration for the Survival of Patients With Ovarian Carcinoma
      MONA DAWOOD, EDNAH OOKO, THOMAS EFFERTH and JOELLE C. BOULOS
      Anticancer Research May 2026, 46 (5) 2877-2886; DOI: https://doi.org/10.21873/anticanres.18166
    • You have access
      Risk Factors for Niraparib-induced Severe Anemia in Japanese Patients With Ovarian Cancer: A Multicenter Study
      YUKI OZAWA, HIROMU TANIGAWA, TATSUHIRO FUJIMIYA, YOSHIKI ABE, JOH HIROHARA, MARII SUEHIRO, YUKI TANAKA, NAOKI SHIBATA, TAKASHI YOKOKAWA, JUNICHI KUSANO, TORU ARASE and TAKUMA KOINUMA
      Anticancer Research May 2026, 46 (5) 2887-2897; DOI: https://doi.org/10.21873/anticanres.18167
    • You have access
      Ascites: A Potential Diagnostic Surrogate for Genetic Profiling in Ovarian Cancer
      ESTRID V. HØGDALL, LAU K. VESTERGAARD, DOUGLAS N.P. OLIVEIRA, TIM S. POULSEN and CLAUS K. HØGDALL
      Anticancer Research May 2026, 46 (5) 2899-2913; DOI: https://doi.org/10.21873/anticanres.18168
    • You have access
      The Ovarian Portal: An Unusual Pathway to Discovery, A Rare Initial Manifestation of Colon Cancer
      NASIM SALIMIAGHDAM, XUEBIN YANG and HONGYAN LIANG
      Anticancer Research May 2026, 46 (5) 2915-2923; DOI: https://doi.org/10.21873/anticanres.18169
    • You have access
      Ovarian Sertoli Cell Tumor Coexisting With Uterine Malformation: A Case Report
      OLIWIA BIEGAŃSKA, EMILIA BICZAK, GRZEGORZ PRZYWARA, RADOSŁAW BLOK, ŁUKASZ FUŁAWKA, AGNIESZKA HAŁOŃ and MAREK MURAWSKI
      Anticancer Research May 2026, 46 (5) 2925-2936; DOI: https://doi.org/10.21873/anticanres.18170
    • You have access
      Ovarian Metastasis from EBV-Associated Undifferentiated Nasopharyngeal Carcinoma: An Exceptionally Rare Occurrence
      HATICE AVSAR, IMDAT EROGLU, AYSENUR DEMIRCI, IPEK ISIK GONUL and AYTUG UNER
      Anticancer Research May 2026, 46 (5) 2937-2943; DOI: https://doi.org/10.21873/anticanres.18171
Back to top
Previous

In this issue

Anticancer Research: 46 (5)
Anticancer Research
Vol. 46, Issue 5
May 2026
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)

Issue highlights

  • Musashi1 Enhances Cell Growth and Increases Chemoresistance in Neuroblastoma
  • Gossypol Inhibits GLI3-dependent SHH Signaling to Selectively Target SPOP-deficient Breast Cancer Cells
  • Serum Extracellular Vesicles Double-positive for CD9 and CD147 or for CD9 and CD63 Decrease After Surgical Resection in Patients With Colorectal Cancer: Potential Biomarkers of Residual Tumor
  • Real-world Delivery and Outcomes of Intravesical BCG for Non–muscle-invasive Bladder Cancer
  • PRDX4 Potentially Serves as an Independent Marker for Early Recurrence of Oral Squamous Cell Carcinoma
Sign up for alerts

Jump to

  • Review
  • Experimental Studies
  • Clinical Studies
  • Special Issue on “Ovarian Cancer Immunology and Immunotherapy – 2026”
    • Editorial Note
    • Reviews
    • Articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire